Treg have been implicated in myeloma progression based on their contribution to the complex immunosuppressive environment through secretion of cytokines IL-10 and TGF-β (29), as well as direct inhibition of effector T cell responses (30). The gene discussed is IL10; the disease is plasma cell myeloma.